RUBIVITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rubivite, and what generic alternatives are available?
Rubivite is a drug marketed by Bel Mar and is included in one NDA.
The generic ingredient in RUBIVITE is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rubivite
A generic version of RUBIVITE was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RUBIVITE?
- What are the global sales for RUBIVITE?
- What is Average Wholesale Price for RUBIVITE?
Summary for RUBIVITE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Patent Applications: | 57 |
DailyMed Link: | RUBIVITE at DailyMed |
US Patents and Regulatory Information for RUBIVITE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bel Mar | RUBIVITE | cyanocobalamin | INJECTABLE;INJECTION | 010791-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bel Mar | RUBIVITE | cyanocobalamin | INJECTABLE;INJECTION | 010791-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bel Mar | RUBIVITE | cyanocobalamin | INJECTABLE;INJECTION | 010791-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bel Mar | RUBIVITE | cyanocobalamin | INJECTABLE;INJECTION | 010791-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Bel Mar | RUBIVITE | cyanocobalamin | INJECTABLE;INJECTION | 010791-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |